Advertisement
Research Article

Relationship between Food Insecurity and Mortality among HIV-Positive Injection Drug Users Receiving Antiretroviral Therapy in British Columbia, Canada

  • Aranka Anema mail,

    aanema@cfenet.ubc.ca

    Affiliations: British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    X
  • Keith Chan,

    Affiliation: Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    X
  • Yalin Chen,

    Affiliation: Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    X
  • Sheri Weiser,

    Affiliations: Division of HIV/AIDS, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, United States of America

    X
  • Julio S. G. Montaner,

    Affiliations: British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    X
  • Robert S. Hogg

    Affiliations: British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada, Faculty of Health Sciences, University of British Columbia, Burnaby, British Columbia, Canada

    X
  • Published: May 27, 2013
  • DOI: 10.1371/journal.pone.0061277

About the Authors

Aranka Anema, Julio S. G. Montaner, Robert S. Hogg
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada
Aranka Anema, Keith Chan, Yalin Chen, Julio S. G. Montaner
Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Sheri Weiser
Division of HIV/AIDS, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
Sheri Weiser
Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, United States of America
Robert S. Hogg
Faculty of Health Sciences, University of British Columbia, Burnaby, British Columbia, Canada

Corresponding Author

Email: aanema@cfenet.ubc.ca

Competing Interests

Julio S. G. Montaner has received educational grants from, served as an ad hoc adviser to or spoken at various events sponsored by Abbott Laboratories, Agouron Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc., Borean Pharma AS, Bristol-Myers Squibb, DuPont Pharma, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Immune Response Corporation, Incyte, Janssen-Ortho Inc., Kucera Pharmaceutical Company, Merck Frosst Laboratories, Pfizer Canada Inc., Sanofi Pasteur, Shire Biochem Inc., Tibotec Pharmaceuticals Ltd. and Trimeris Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors′ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Contributed specialist knowledge and critical review/feedback on manuscript drafts: SDW JSGM RSH. Conceived and designed the experiments: AA RSH. Analyzed the data: AA KC YC. Wrote the paper: AA.